Global Peptide Synthesis Supply, Demand and Key Producers, 2026-2032
The global Peptide Synthesis market size is expected to reach $ 1183 million by 2032, rising at a market growth of 6.5% CAGR during the forecast period (2026-2032).
Peptide synthesis refers to the process of linking multiple amino acids into a peptide chain in a specified sequence by chemical or biochemical methods. These peptides may serve as therapeutics, diagnostic reagents, biomarkers, or research tools. Peptides are generally shorter than proteins — most often composed of no more than 40-60 amino acid residues — though their structures can be complex, including non-natural or modified amino acids, cyclizations, conjugations with chemical moieties or labels. The main techniques for peptide synthesis include solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), hybrid/convergent methods, enzymatic or recombinant expression methods. The synthetic workflow typically involves protecting and deprotecting amino acids, peptide bond formation (coupling), support/resin anchoring or carrier systems, purification (such as chromatographic steps, precipitations, etc.), and rigorous quality control (structure confirmation, stereochemical purity, impurity/residual solvent analysis). With the rapid expansion of peptide-based drugs, diagnostics, and cosmetic applications, combined with growing demand for high specificity, low toxicity, and strong biocompatibility, peptide synthesis has become a cornerstone in biopharma and life science R&D.
The peptide synthesis market currently stands at a multi-accelerated inflection point. On one side, peptide-based therapeutics are being increasingly recognized in fields such as chronic diseases, metabolic disorders, oncology, and neurodegeneration: their high specificity, low systemic toxicity, and novel targeting mechanisms make them promising where traditional small molecules or large proteins struggle. On another side, governments and regulatory agencies in many countries (including the U.S., EU, Japan, China, etc.) are introducing policies that support innovation, streamline approval pathways for novel peptides or peptide/oligonucleotide (TIDES) drugs, and shorten clinical trial and regulatory review timelines, thereby enlarging market opportunity for peptide synthesis providers. On the technical front, continued progress in solid-phase synthesis (SPPS), liquid-phase methods (LPPS), hybrid / convergent synthesis, and enhanced capabilities for complex structures (including non-natural amino acids, cyclization, peptide-drug conjugates) are pushing the market toward larger scale, higher quality, and greater structural diversity. In addition, downstream CDMO/CRO outsourcing demand is rising sharply: drug developers are increasingly preferring to externalize process development, scale-up, and clinical/registration production to specialized synthesis/manufacturing entities to reduce capital burden and risk. Emerging economies (e.g. China, India, South Korea) are also providing strong growth drivers due to their rising healthcare needs, biotech investment, lower manufacturing cost bases, and favorable policy incentives.
However, the peptide synthesis market is not without substantial challenges and risks. First, synthesizing long or complex peptides (with modifications, non-natural residues, cyclization, hydrophobic sequences etc.) amplifies problems of low coupling efficiency, incomplete reactions, racemization, side-product formation — these reduce yield and make purification expensive and difficult. Second, the supply chain stability and cost volatility for upstream raw materials (high-purity protected amino acids, specialized coupling reagents, protective groups, rare or synthetic modified amino acids) is high; environmental / safety laws regulating chemical reagents and solvents impose increasing constraints. Third, downstream purification and quality control steps (chromatography, removal of residual reagents/protection groups/solvents, structure confirmation, stereochemical purity) require heavy equipment investment, long cycles, and high operating costs, particularly at clinical/commercial scale. Regulatory risk is also real: differing national definitions of peptides vs biologics (or other categories), regulatory standards, and environmental / chemical safety policies may shift, increasing compliance cost or causing delays. Finally, competitive pressures and pricing squeeze are intensifying, especially among CDMOs / synthesis service providers, and in emerging markets focusing on low cost; maintaining high quality, speed, and regulatory compliance becomes a differentiator but also a cost center.
Downstream demand is evolving in several concurrent directions. Therapeutic peptides continue to be the largest pull: more peptide drugs are gaining regulatory approval, and the R&D pipeline is expanding, especially in metabolic disease (e.g. obesity, diabetes), oncology, endocrine regulation, and infectious diseases. In several disease areas, peptide-drug conjugates and peptide vaccines are emerging as key focus areas. Beyond therapeutics, diagnostic and imaging labelled peptides are growing demand, e.g. biomarkers, in vitro diagnostics (IVD) and radiolabelled or fluorescent labelled small peptides, especially in precision medicine. The cosmetics / beauty sector is also actively introducing peptides with anti-aging, repair, collagen-boosting, antioxidative functionalities, with rising consumer and brand expectations for natural or bio-active, safety validated ingredients. Research and basic science needs remain stable, being driven by automation and high-throughput synthesis tools, giving academic institutions and biotech startups need for more flexible, fast, custom peptide synthesis services. Overall, downstream demand is trending toward more complex structures / high modifications / higher purity / more individualized use, and demands for faster turnaround and higher service quality.
This report studies the global Peptide Synthesis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peptide Synthesis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide Synthesis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peptide Synthesis total market, 2021-2032, (USD Million)
Global Peptide Synthesis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peptide Synthesis total market, key domestic companies, and share, (USD Million)
Global Peptide Synthesis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peptide Synthesis total market by Type, CAGR, 2021-2032, (USD Million)
Global Peptide Synthesis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peptide Synthesis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peptide Synthesis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peptide Synthesis Market, By Region:
1. How big is the global Peptide Synthesis market?
2. What is the demand of the global Peptide Synthesis market?
3. What is the year over year growth of the global Peptide Synthesis market?
4. What is the total value of the global Peptide Synthesis market?
5. Who are the Major Players in the global Peptide Synthesis market?
6. What are the growth factors driving the market demand?
Peptide synthesis refers to the process of linking multiple amino acids into a peptide chain in a specified sequence by chemical or biochemical methods. These peptides may serve as therapeutics, diagnostic reagents, biomarkers, or research tools. Peptides are generally shorter than proteins — most often composed of no more than 40-60 amino acid residues — though their structures can be complex, including non-natural or modified amino acids, cyclizations, conjugations with chemical moieties or labels. The main techniques for peptide synthesis include solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), hybrid/convergent methods, enzymatic or recombinant expression methods. The synthetic workflow typically involves protecting and deprotecting amino acids, peptide bond formation (coupling), support/resin anchoring or carrier systems, purification (such as chromatographic steps, precipitations, etc.), and rigorous quality control (structure confirmation, stereochemical purity, impurity/residual solvent analysis). With the rapid expansion of peptide-based drugs, diagnostics, and cosmetic applications, combined with growing demand for high specificity, low toxicity, and strong biocompatibility, peptide synthesis has become a cornerstone in biopharma and life science R&D.
The peptide synthesis market currently stands at a multi-accelerated inflection point. On one side, peptide-based therapeutics are being increasingly recognized in fields such as chronic diseases, metabolic disorders, oncology, and neurodegeneration: their high specificity, low systemic toxicity, and novel targeting mechanisms make them promising where traditional small molecules or large proteins struggle. On another side, governments and regulatory agencies in many countries (including the U.S., EU, Japan, China, etc.) are introducing policies that support innovation, streamline approval pathways for novel peptides or peptide/oligonucleotide (TIDES) drugs, and shorten clinical trial and regulatory review timelines, thereby enlarging market opportunity for peptide synthesis providers. On the technical front, continued progress in solid-phase synthesis (SPPS), liquid-phase methods (LPPS), hybrid / convergent synthesis, and enhanced capabilities for complex structures (including non-natural amino acids, cyclization, peptide-drug conjugates) are pushing the market toward larger scale, higher quality, and greater structural diversity. In addition, downstream CDMO/CRO outsourcing demand is rising sharply: drug developers are increasingly preferring to externalize process development, scale-up, and clinical/registration production to specialized synthesis/manufacturing entities to reduce capital burden and risk. Emerging economies (e.g. China, India, South Korea) are also providing strong growth drivers due to their rising healthcare needs, biotech investment, lower manufacturing cost bases, and favorable policy incentives.
However, the peptide synthesis market is not without substantial challenges and risks. First, synthesizing long or complex peptides (with modifications, non-natural residues, cyclization, hydrophobic sequences etc.) amplifies problems of low coupling efficiency, incomplete reactions, racemization, side-product formation — these reduce yield and make purification expensive and difficult. Second, the supply chain stability and cost volatility for upstream raw materials (high-purity protected amino acids, specialized coupling reagents, protective groups, rare or synthetic modified amino acids) is high; environmental / safety laws regulating chemical reagents and solvents impose increasing constraints. Third, downstream purification and quality control steps (chromatography, removal of residual reagents/protection groups/solvents, structure confirmation, stereochemical purity) require heavy equipment investment, long cycles, and high operating costs, particularly at clinical/commercial scale. Regulatory risk is also real: differing national definitions of peptides vs biologics (or other categories), regulatory standards, and environmental / chemical safety policies may shift, increasing compliance cost or causing delays. Finally, competitive pressures and pricing squeeze are intensifying, especially among CDMOs / synthesis service providers, and in emerging markets focusing on low cost; maintaining high quality, speed, and regulatory compliance becomes a differentiator but also a cost center.
Downstream demand is evolving in several concurrent directions. Therapeutic peptides continue to be the largest pull: more peptide drugs are gaining regulatory approval, and the R&D pipeline is expanding, especially in metabolic disease (e.g. obesity, diabetes), oncology, endocrine regulation, and infectious diseases. In several disease areas, peptide-drug conjugates and peptide vaccines are emerging as key focus areas. Beyond therapeutics, diagnostic and imaging labelled peptides are growing demand, e.g. biomarkers, in vitro diagnostics (IVD) and radiolabelled or fluorescent labelled small peptides, especially in precision medicine. The cosmetics / beauty sector is also actively introducing peptides with anti-aging, repair, collagen-boosting, antioxidative functionalities, with rising consumer and brand expectations for natural or bio-active, safety validated ingredients. Research and basic science needs remain stable, being driven by automation and high-throughput synthesis tools, giving academic institutions and biotech startups need for more flexible, fast, custom peptide synthesis services. Overall, downstream demand is trending toward more complex structures / high modifications / higher purity / more individualized use, and demands for faster turnaround and higher service quality.
This report studies the global Peptide Synthesis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peptide Synthesis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide Synthesis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peptide Synthesis total market, 2021-2032, (USD Million)
Global Peptide Synthesis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peptide Synthesis total market, key domestic companies, and share, (USD Million)
Global Peptide Synthesis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peptide Synthesis total market by Type, CAGR, 2021-2032, (USD Million)
Global Peptide Synthesis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peptide Synthesis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peptide Synthesis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peptide Synthesis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- APIs and Intermediates
- Peptide preparations
- Commercial
- Academic Research
- Bachem
- PolyPeptide
- CordenPharma
- AmbioPharm
- USV Peptides
- Thermofischer
- Bio Basic
- JPT
- Genscript
- Xinbang Pharma
- ScinoPharm
- SN Biopharm
- CBL
- Piramal Pharma
- CPC Scientific
- Shenzhen Hanyu
1. How big is the global Peptide Synthesis market?
2. What is the demand of the global Peptide Synthesis market?
3. What is the year over year growth of the global Peptide Synthesis market?
4. What is the total value of the global Peptide Synthesis market?
5. Who are the Major Players in the global Peptide Synthesis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Peptide Synthesis Introduction
1.2 World Peptide Synthesis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Peptide Synthesis Total Market by Region (by Headquarter Location)
1.3.1 World Peptide Synthesis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Peptide Synthesis Revenue (2021-2032)
1.3.3 China Based Company Peptide Synthesis Revenue (2021-2032)
1.3.4 Europe Based Company Peptide Synthesis Revenue (2021-2032)
1.3.5 Japan Based Company Peptide Synthesis Revenue (2021-2032)
1.3.6 South Korea Based Company Peptide Synthesis Revenue (2021-2032)
1.3.7 ASEAN Based Company Peptide Synthesis Revenue (2021-2032)
1.3.8 India Based Company Peptide Synthesis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peptide Synthesis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Peptide Synthesis Consumption Value (2021-2032)
2.2 World Peptide Synthesis Consumption Value by Region
2.2.1 World Peptide Synthesis Consumption Value by Region (2021-2026)
2.2.2 World Peptide Synthesis Consumption Value Forecast by Region (2027-2032)
2.3 United States Peptide Synthesis Consumption Value (2021-2032)
2.4 China Peptide Synthesis Consumption Value (2021-2032)
2.5 Europe Peptide Synthesis Consumption Value (2021-2032)
2.6 Japan Peptide Synthesis Consumption Value (2021-2032)
2.7 South Korea Peptide Synthesis Consumption Value (2021-2032)
2.8 ASEAN Peptide Synthesis Consumption Value (2021-2032)
2.9 India Peptide Synthesis Consumption Value (2021-2032)
3 WORLD PEPTIDE SYNTHESIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Peptide Synthesis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Peptide Synthesis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Peptide Synthesis in 2025
3.2.3 Global Concentration Ratios (CR8) for Peptide Synthesis in 2025
3.3 Peptide Synthesis Company Evaluation Quadrant
3.4 Peptide Synthesis Market: Overall Company Footprint Analysis
3.4.1 Peptide Synthesis Market: Region Footprint
3.4.2 Peptide Synthesis Market: Company Product Type Footprint
3.4.3 Peptide Synthesis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Peptide Synthesis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Peptide Synthesis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Peptide Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Peptide Synthesis Consumption Value Comparison
4.2.1 United States VS China: Peptide Synthesis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Peptide Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Peptide Synthesis Companies and Market Share, 2021-2026
4.3.1 United States Based Peptide Synthesis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Peptide Synthesis Revenue, (2021-2026)
4.4 China Based Companies Peptide Synthesis Revenue and Market Share, 2021-2026
4.4.1 China Based Peptide Synthesis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Peptide Synthesis Revenue, (2021-2026)
4.5 Rest of World Based Peptide Synthesis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Peptide Synthesis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Peptide Synthesis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Peptide Synthesis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 APIs and Intermediates
5.2.2 Peptide preparations
5.3 Market Segment by Type
5.3.1 World Peptide Synthesis Market Size by Type (2021-2026)
5.3.2 World Peptide Synthesis Market Size by Type (2027-2032)
5.3.3 World Peptide Synthesis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Peptide Synthesis Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Academic Research
6.3 Market Segment by Application
6.3.1 World Peptide Synthesis Market Size by Application (2021-2026)
6.3.2 World Peptide Synthesis Market Size by Application (2027-2032)
6.3.3 World Peptide Synthesis Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Bachem
7.1.1 Bachem Details
7.1.2 Bachem Major Business
7.1.3 Bachem Peptide Synthesis Product and Services
7.1.4 Bachem Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Bachem Recent Developments/Updates
7.1.6 Bachem Competitive Strengths & Weaknesses
7.2 PolyPeptide
7.2.1 PolyPeptide Details
7.2.2 PolyPeptide Major Business
7.2.3 PolyPeptide Peptide Synthesis Product and Services
7.2.4 PolyPeptide Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 PolyPeptide Recent Developments/Updates
7.2.6 PolyPeptide Competitive Strengths & Weaknesses
7.3 CordenPharma
7.3.1 CordenPharma Details
7.3.2 CordenPharma Major Business
7.3.3 CordenPharma Peptide Synthesis Product and Services
7.3.4 CordenPharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 CordenPharma Recent Developments/Updates
7.3.6 CordenPharma Competitive Strengths & Weaknesses
7.4 AmbioPharm
7.4.1 AmbioPharm Details
7.4.2 AmbioPharm Major Business
7.4.3 AmbioPharm Peptide Synthesis Product and Services
7.4.4 AmbioPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 AmbioPharm Recent Developments/Updates
7.4.6 AmbioPharm Competitive Strengths & Weaknesses
7.5 USV Peptides
7.5.1 USV Peptides Details
7.5.2 USV Peptides Major Business
7.5.3 USV Peptides Peptide Synthesis Product and Services
7.5.4 USV Peptides Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 USV Peptides Recent Developments/Updates
7.5.6 USV Peptides Competitive Strengths & Weaknesses
7.6 Thermofischer
7.6.1 Thermofischer Details
7.6.2 Thermofischer Major Business
7.6.3 Thermofischer Peptide Synthesis Product and Services
7.6.4 Thermofischer Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Thermofischer Recent Developments/Updates
7.6.6 Thermofischer Competitive Strengths & Weaknesses
7.7 Bio Basic
7.7.1 Bio Basic Details
7.7.2 Bio Basic Major Business
7.7.3 Bio Basic Peptide Synthesis Product and Services
7.7.4 Bio Basic Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Bio Basic Recent Developments/Updates
7.7.6 Bio Basic Competitive Strengths & Weaknesses
7.8 JPT
7.8.1 JPT Details
7.8.2 JPT Major Business
7.8.3 JPT Peptide Synthesis Product and Services
7.8.4 JPT Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 JPT Recent Developments/Updates
7.8.6 JPT Competitive Strengths & Weaknesses
7.9 Genscript
7.9.1 Genscript Details
7.9.2 Genscript Major Business
7.9.3 Genscript Peptide Synthesis Product and Services
7.9.4 Genscript Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Genscript Recent Developments/Updates
7.9.6 Genscript Competitive Strengths & Weaknesses
7.10 Xinbang Pharma
7.10.1 Xinbang Pharma Details
7.10.2 Xinbang Pharma Major Business
7.10.3 Xinbang Pharma Peptide Synthesis Product and Services
7.10.4 Xinbang Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Xinbang Pharma Recent Developments/Updates
7.10.6 Xinbang Pharma Competitive Strengths & Weaknesses
7.11 ScinoPharm
7.11.1 ScinoPharm Details
7.11.2 ScinoPharm Major Business
7.11.3 ScinoPharm Peptide Synthesis Product and Services
7.11.4 ScinoPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 ScinoPharm Recent Developments/Updates
7.11.6 ScinoPharm Competitive Strengths & Weaknesses
7.12 SN Biopharm
7.12.1 SN Biopharm Details
7.12.2 SN Biopharm Major Business
7.12.3 SN Biopharm Peptide Synthesis Product and Services
7.12.4 SN Biopharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 SN Biopharm Recent Developments/Updates
7.12.6 SN Biopharm Competitive Strengths & Weaknesses
7.13 CBL
7.13.1 CBL Details
7.13.2 CBL Major Business
7.13.3 CBL Peptide Synthesis Product and Services
7.13.4 CBL Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 CBL Recent Developments/Updates
7.13.6 CBL Competitive Strengths & Weaknesses
7.14 Piramal Pharma
7.14.1 Piramal Pharma Details
7.14.2 Piramal Pharma Major Business
7.14.3 Piramal Pharma Peptide Synthesis Product and Services
7.14.4 Piramal Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Piramal Pharma Recent Developments/Updates
7.14.6 Piramal Pharma Competitive Strengths & Weaknesses
7.15 CPC Scientific
7.15.1 CPC Scientific Details
7.15.2 CPC Scientific Major Business
7.15.3 CPC Scientific Peptide Synthesis Product and Services
7.15.4 CPC Scientific Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 CPC Scientific Recent Developments/Updates
7.15.6 CPC Scientific Competitive Strengths & Weaknesses
7.16 Shenzhen Hanyu
7.16.1 Shenzhen Hanyu Details
7.16.2 Shenzhen Hanyu Major Business
7.16.3 Shenzhen Hanyu Peptide Synthesis Product and Services
7.16.4 Shenzhen Hanyu Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 Shenzhen Hanyu Recent Developments/Updates
7.16.6 Shenzhen Hanyu Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Peptide Synthesis Industry Chain
8.2 Peptide Synthesis Upstream Analysis
8.3 Peptide Synthesis Midstream Analysis
8.4 Peptide Synthesis Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Peptide Synthesis Introduction
1.2 World Peptide Synthesis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Peptide Synthesis Total Market by Region (by Headquarter Location)
1.3.1 World Peptide Synthesis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Peptide Synthesis Revenue (2021-2032)
1.3.3 China Based Company Peptide Synthesis Revenue (2021-2032)
1.3.4 Europe Based Company Peptide Synthesis Revenue (2021-2032)
1.3.5 Japan Based Company Peptide Synthesis Revenue (2021-2032)
1.3.6 South Korea Based Company Peptide Synthesis Revenue (2021-2032)
1.3.7 ASEAN Based Company Peptide Synthesis Revenue (2021-2032)
1.3.8 India Based Company Peptide Synthesis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peptide Synthesis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Peptide Synthesis Consumption Value (2021-2032)
2.2 World Peptide Synthesis Consumption Value by Region
2.2.1 World Peptide Synthesis Consumption Value by Region (2021-2026)
2.2.2 World Peptide Synthesis Consumption Value Forecast by Region (2027-2032)
2.3 United States Peptide Synthesis Consumption Value (2021-2032)
2.4 China Peptide Synthesis Consumption Value (2021-2032)
2.5 Europe Peptide Synthesis Consumption Value (2021-2032)
2.6 Japan Peptide Synthesis Consumption Value (2021-2032)
2.7 South Korea Peptide Synthesis Consumption Value (2021-2032)
2.8 ASEAN Peptide Synthesis Consumption Value (2021-2032)
2.9 India Peptide Synthesis Consumption Value (2021-2032)
3 WORLD PEPTIDE SYNTHESIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Peptide Synthesis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Peptide Synthesis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Peptide Synthesis in 2025
3.2.3 Global Concentration Ratios (CR8) for Peptide Synthesis in 2025
3.3 Peptide Synthesis Company Evaluation Quadrant
3.4 Peptide Synthesis Market: Overall Company Footprint Analysis
3.4.1 Peptide Synthesis Market: Region Footprint
3.4.2 Peptide Synthesis Market: Company Product Type Footprint
3.4.3 Peptide Synthesis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Peptide Synthesis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Peptide Synthesis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Peptide Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Peptide Synthesis Consumption Value Comparison
4.2.1 United States VS China: Peptide Synthesis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Peptide Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Peptide Synthesis Companies and Market Share, 2021-2026
4.3.1 United States Based Peptide Synthesis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Peptide Synthesis Revenue, (2021-2026)
4.4 China Based Companies Peptide Synthesis Revenue and Market Share, 2021-2026
4.4.1 China Based Peptide Synthesis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Peptide Synthesis Revenue, (2021-2026)
4.5 Rest of World Based Peptide Synthesis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Peptide Synthesis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Peptide Synthesis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Peptide Synthesis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 APIs and Intermediates
5.2.2 Peptide preparations
5.3 Market Segment by Type
5.3.1 World Peptide Synthesis Market Size by Type (2021-2026)
5.3.2 World Peptide Synthesis Market Size by Type (2027-2032)
5.3.3 World Peptide Synthesis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Peptide Synthesis Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Academic Research
6.3 Market Segment by Application
6.3.1 World Peptide Synthesis Market Size by Application (2021-2026)
6.3.2 World Peptide Synthesis Market Size by Application (2027-2032)
6.3.3 World Peptide Synthesis Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Bachem
7.1.1 Bachem Details
7.1.2 Bachem Major Business
7.1.3 Bachem Peptide Synthesis Product and Services
7.1.4 Bachem Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Bachem Recent Developments/Updates
7.1.6 Bachem Competitive Strengths & Weaknesses
7.2 PolyPeptide
7.2.1 PolyPeptide Details
7.2.2 PolyPeptide Major Business
7.2.3 PolyPeptide Peptide Synthesis Product and Services
7.2.4 PolyPeptide Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 PolyPeptide Recent Developments/Updates
7.2.6 PolyPeptide Competitive Strengths & Weaknesses
7.3 CordenPharma
7.3.1 CordenPharma Details
7.3.2 CordenPharma Major Business
7.3.3 CordenPharma Peptide Synthesis Product and Services
7.3.4 CordenPharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 CordenPharma Recent Developments/Updates
7.3.6 CordenPharma Competitive Strengths & Weaknesses
7.4 AmbioPharm
7.4.1 AmbioPharm Details
7.4.2 AmbioPharm Major Business
7.4.3 AmbioPharm Peptide Synthesis Product and Services
7.4.4 AmbioPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 AmbioPharm Recent Developments/Updates
7.4.6 AmbioPharm Competitive Strengths & Weaknesses
7.5 USV Peptides
7.5.1 USV Peptides Details
7.5.2 USV Peptides Major Business
7.5.3 USV Peptides Peptide Synthesis Product and Services
7.5.4 USV Peptides Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 USV Peptides Recent Developments/Updates
7.5.6 USV Peptides Competitive Strengths & Weaknesses
7.6 Thermofischer
7.6.1 Thermofischer Details
7.6.2 Thermofischer Major Business
7.6.3 Thermofischer Peptide Synthesis Product and Services
7.6.4 Thermofischer Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Thermofischer Recent Developments/Updates
7.6.6 Thermofischer Competitive Strengths & Weaknesses
7.7 Bio Basic
7.7.1 Bio Basic Details
7.7.2 Bio Basic Major Business
7.7.3 Bio Basic Peptide Synthesis Product and Services
7.7.4 Bio Basic Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Bio Basic Recent Developments/Updates
7.7.6 Bio Basic Competitive Strengths & Weaknesses
7.8 JPT
7.8.1 JPT Details
7.8.2 JPT Major Business
7.8.3 JPT Peptide Synthesis Product and Services
7.8.4 JPT Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 JPT Recent Developments/Updates
7.8.6 JPT Competitive Strengths & Weaknesses
7.9 Genscript
7.9.1 Genscript Details
7.9.2 Genscript Major Business
7.9.3 Genscript Peptide Synthesis Product and Services
7.9.4 Genscript Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Genscript Recent Developments/Updates
7.9.6 Genscript Competitive Strengths & Weaknesses
7.10 Xinbang Pharma
7.10.1 Xinbang Pharma Details
7.10.2 Xinbang Pharma Major Business
7.10.3 Xinbang Pharma Peptide Synthesis Product and Services
7.10.4 Xinbang Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Xinbang Pharma Recent Developments/Updates
7.10.6 Xinbang Pharma Competitive Strengths & Weaknesses
7.11 ScinoPharm
7.11.1 ScinoPharm Details
7.11.2 ScinoPharm Major Business
7.11.3 ScinoPharm Peptide Synthesis Product and Services
7.11.4 ScinoPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 ScinoPharm Recent Developments/Updates
7.11.6 ScinoPharm Competitive Strengths & Weaknesses
7.12 SN Biopharm
7.12.1 SN Biopharm Details
7.12.2 SN Biopharm Major Business
7.12.3 SN Biopharm Peptide Synthesis Product and Services
7.12.4 SN Biopharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 SN Biopharm Recent Developments/Updates
7.12.6 SN Biopharm Competitive Strengths & Weaknesses
7.13 CBL
7.13.1 CBL Details
7.13.2 CBL Major Business
7.13.3 CBL Peptide Synthesis Product and Services
7.13.4 CBL Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 CBL Recent Developments/Updates
7.13.6 CBL Competitive Strengths & Weaknesses
7.14 Piramal Pharma
7.14.1 Piramal Pharma Details
7.14.2 Piramal Pharma Major Business
7.14.3 Piramal Pharma Peptide Synthesis Product and Services
7.14.4 Piramal Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Piramal Pharma Recent Developments/Updates
7.14.6 Piramal Pharma Competitive Strengths & Weaknesses
7.15 CPC Scientific
7.15.1 CPC Scientific Details
7.15.2 CPC Scientific Major Business
7.15.3 CPC Scientific Peptide Synthesis Product and Services
7.15.4 CPC Scientific Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 CPC Scientific Recent Developments/Updates
7.15.6 CPC Scientific Competitive Strengths & Weaknesses
7.16 Shenzhen Hanyu
7.16.1 Shenzhen Hanyu Details
7.16.2 Shenzhen Hanyu Major Business
7.16.3 Shenzhen Hanyu Peptide Synthesis Product and Services
7.16.4 Shenzhen Hanyu Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 Shenzhen Hanyu Recent Developments/Updates
7.16.6 Shenzhen Hanyu Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Peptide Synthesis Industry Chain
8.2 Peptide Synthesis Upstream Analysis
8.3 Peptide Synthesis Midstream Analysis
8.4 Peptide Synthesis Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Peptide Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Peptide Synthesis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Peptide Synthesis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Peptide Synthesis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Peptide Synthesis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Peptide Synthesis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Peptide Synthesis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Peptide Synthesis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Peptide Synthesis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Peptide Synthesis Players in 2025
Table 12. World Peptide Synthesis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Peptide Synthesis Company Evaluation Quadrant
Table 14. Head Office of Key Peptide Synthesis Players
Table 15. Peptide Synthesis Market: Company Product Type Footprint
Table 16. Peptide Synthesis Market: Company Product Application Footprint
Table 17. Peptide Synthesis Mergers & Acquisitions Activity
Table 18. United States VS China Peptide Synthesis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Peptide Synthesis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Peptide Synthesis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Peptide Synthesis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Peptide Synthesis Revenue Market Share (2021-2026)
Table 23. China Based Peptide Synthesis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Peptide Synthesis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Peptide Synthesis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Peptide Synthesis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Peptide Synthesis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Peptide Synthesis Revenue Market Share (2021-2026)
Table 29. World Peptide Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Peptide Synthesis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Peptide Synthesis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Peptide Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Peptide Synthesis Market Size by Application (2021-2026) & (USD Million)
Table 34. World Peptide Synthesis Market Size by Application (2027-2032) & (USD Million)
Table 35. Bachem Basic Information, Manufacturing Base and Competitors
Table 36. Bachem Major Business
Table 37. Bachem Peptide Synthesis Product and Services
Table 38. Bachem Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Bachem Recent Developments/Updates
Table 40. Bachem Competitive Strengths & Weaknesses
Table 41. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 42. PolyPeptide Major Business
Table 43. PolyPeptide Peptide Synthesis Product and Services
Table 44. PolyPeptide Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. PolyPeptide Recent Developments/Updates
Table 46. PolyPeptide Competitive Strengths & Weaknesses
Table 47. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 48. CordenPharma Major Business
Table 49. CordenPharma Peptide Synthesis Product and Services
Table 50. CordenPharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. CordenPharma Recent Developments/Updates
Table 52. CordenPharma Competitive Strengths & Weaknesses
Table 53. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 54. AmbioPharm Major Business
Table 55. AmbioPharm Peptide Synthesis Product and Services
Table 56. AmbioPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. AmbioPharm Recent Developments/Updates
Table 58. AmbioPharm Competitive Strengths & Weaknesses
Table 59. USV Peptides Basic Information, Manufacturing Base and Competitors
Table 60. USV Peptides Major Business
Table 61. USV Peptides Peptide Synthesis Product and Services
Table 62. USV Peptides Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. USV Peptides Recent Developments/Updates
Table 64. USV Peptides Competitive Strengths & Weaknesses
Table 65. Thermofischer Basic Information, Manufacturing Base and Competitors
Table 66. Thermofischer Major Business
Table 67. Thermofischer Peptide Synthesis Product and Services
Table 68. Thermofischer Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Thermofischer Recent Developments/Updates
Table 70. Thermofischer Competitive Strengths & Weaknesses
Table 71. Bio Basic Basic Information, Manufacturing Base and Competitors
Table 72. Bio Basic Major Business
Table 73. Bio Basic Peptide Synthesis Product and Services
Table 74. Bio Basic Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Bio Basic Recent Developments/Updates
Table 76. Bio Basic Competitive Strengths & Weaknesses
Table 77. JPT Basic Information, Manufacturing Base and Competitors
Table 78. JPT Major Business
Table 79. JPT Peptide Synthesis Product and Services
Table 80. JPT Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. JPT Recent Developments/Updates
Table 82. JPT Competitive Strengths & Weaknesses
Table 83. Genscript Basic Information, Manufacturing Base and Competitors
Table 84. Genscript Major Business
Table 85. Genscript Peptide Synthesis Product and Services
Table 86. Genscript Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Genscript Recent Developments/Updates
Table 88. Genscript Competitive Strengths & Weaknesses
Table 89. Xinbang Pharma Basic Information, Manufacturing Base and Competitors
Table 90. Xinbang Pharma Major Business
Table 91. Xinbang Pharma Peptide Synthesis Product and Services
Table 92. Xinbang Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Xinbang Pharma Recent Developments/Updates
Table 94. Xinbang Pharma Competitive Strengths & Weaknesses
Table 95. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 96. ScinoPharm Major Business
Table 97. ScinoPharm Peptide Synthesis Product and Services
Table 98. ScinoPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. ScinoPharm Recent Developments/Updates
Table 100. ScinoPharm Competitive Strengths & Weaknesses
Table 101. SN Biopharm Basic Information, Manufacturing Base and Competitors
Table 102. SN Biopharm Major Business
Table 103. SN Biopharm Peptide Synthesis Product and Services
Table 104. SN Biopharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. SN Biopharm Recent Developments/Updates
Table 106. SN Biopharm Competitive Strengths & Weaknesses
Table 107. CBL Basic Information, Manufacturing Base and Competitors
Table 108. CBL Major Business
Table 109. CBL Peptide Synthesis Product and Services
Table 110. CBL Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. CBL Recent Developments/Updates
Table 112. CBL Competitive Strengths & Weaknesses
Table 113. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 114. Piramal Pharma Major Business
Table 115. Piramal Pharma Peptide Synthesis Product and Services
Table 116. Piramal Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Piramal Pharma Recent Developments/Updates
Table 118. Piramal Pharma Competitive Strengths & Weaknesses
Table 119. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 120. CPC Scientific Major Business
Table 121. CPC Scientific Peptide Synthesis Product and Services
Table 122. CPC Scientific Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CPC Scientific Recent Developments/Updates
Table 124. CPC Scientific Competitive Strengths & Weaknesses
Table 125. Shenzhen Hanyu Basic Information, Manufacturing Base and Competitors
Table 126. Shenzhen Hanyu Major Business
Table 127. Shenzhen Hanyu Peptide Synthesis Product and Services
Table 128. Shenzhen Hanyu Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Shenzhen Hanyu Recent Developments/Updates
Table 130. Shenzhen Hanyu Competitive Strengths & Weaknesses
Table 131. Global Key Players of Peptide Synthesis Upstream (Raw Materials)
Table 132. Global Peptide Synthesis Typical Customers
Table 1. World Peptide Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Peptide Synthesis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Peptide Synthesis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Peptide Synthesis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Peptide Synthesis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Peptide Synthesis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Peptide Synthesis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Peptide Synthesis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Peptide Synthesis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Peptide Synthesis Players in 2025
Table 12. World Peptide Synthesis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Peptide Synthesis Company Evaluation Quadrant
Table 14. Head Office of Key Peptide Synthesis Players
Table 15. Peptide Synthesis Market: Company Product Type Footprint
Table 16. Peptide Synthesis Market: Company Product Application Footprint
Table 17. Peptide Synthesis Mergers & Acquisitions Activity
Table 18. United States VS China Peptide Synthesis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Peptide Synthesis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Peptide Synthesis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Peptide Synthesis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Peptide Synthesis Revenue Market Share (2021-2026)
Table 23. China Based Peptide Synthesis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Peptide Synthesis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Peptide Synthesis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Peptide Synthesis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Peptide Synthesis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Peptide Synthesis Revenue Market Share (2021-2026)
Table 29. World Peptide Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Peptide Synthesis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Peptide Synthesis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Peptide Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Peptide Synthesis Market Size by Application (2021-2026) & (USD Million)
Table 34. World Peptide Synthesis Market Size by Application (2027-2032) & (USD Million)
Table 35. Bachem Basic Information, Manufacturing Base and Competitors
Table 36. Bachem Major Business
Table 37. Bachem Peptide Synthesis Product and Services
Table 38. Bachem Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Bachem Recent Developments/Updates
Table 40. Bachem Competitive Strengths & Weaknesses
Table 41. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 42. PolyPeptide Major Business
Table 43. PolyPeptide Peptide Synthesis Product and Services
Table 44. PolyPeptide Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. PolyPeptide Recent Developments/Updates
Table 46. PolyPeptide Competitive Strengths & Weaknesses
Table 47. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 48. CordenPharma Major Business
Table 49. CordenPharma Peptide Synthesis Product and Services
Table 50. CordenPharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. CordenPharma Recent Developments/Updates
Table 52. CordenPharma Competitive Strengths & Weaknesses
Table 53. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 54. AmbioPharm Major Business
Table 55. AmbioPharm Peptide Synthesis Product and Services
Table 56. AmbioPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. AmbioPharm Recent Developments/Updates
Table 58. AmbioPharm Competitive Strengths & Weaknesses
Table 59. USV Peptides Basic Information, Manufacturing Base and Competitors
Table 60. USV Peptides Major Business
Table 61. USV Peptides Peptide Synthesis Product and Services
Table 62. USV Peptides Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. USV Peptides Recent Developments/Updates
Table 64. USV Peptides Competitive Strengths & Weaknesses
Table 65. Thermofischer Basic Information, Manufacturing Base and Competitors
Table 66. Thermofischer Major Business
Table 67. Thermofischer Peptide Synthesis Product and Services
Table 68. Thermofischer Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Thermofischer Recent Developments/Updates
Table 70. Thermofischer Competitive Strengths & Weaknesses
Table 71. Bio Basic Basic Information, Manufacturing Base and Competitors
Table 72. Bio Basic Major Business
Table 73. Bio Basic Peptide Synthesis Product and Services
Table 74. Bio Basic Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Bio Basic Recent Developments/Updates
Table 76. Bio Basic Competitive Strengths & Weaknesses
Table 77. JPT Basic Information, Manufacturing Base and Competitors
Table 78. JPT Major Business
Table 79. JPT Peptide Synthesis Product and Services
Table 80. JPT Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. JPT Recent Developments/Updates
Table 82. JPT Competitive Strengths & Weaknesses
Table 83. Genscript Basic Information, Manufacturing Base and Competitors
Table 84. Genscript Major Business
Table 85. Genscript Peptide Synthesis Product and Services
Table 86. Genscript Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Genscript Recent Developments/Updates
Table 88. Genscript Competitive Strengths & Weaknesses
Table 89. Xinbang Pharma Basic Information, Manufacturing Base and Competitors
Table 90. Xinbang Pharma Major Business
Table 91. Xinbang Pharma Peptide Synthesis Product and Services
Table 92. Xinbang Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Xinbang Pharma Recent Developments/Updates
Table 94. Xinbang Pharma Competitive Strengths & Weaknesses
Table 95. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 96. ScinoPharm Major Business
Table 97. ScinoPharm Peptide Synthesis Product and Services
Table 98. ScinoPharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. ScinoPharm Recent Developments/Updates
Table 100. ScinoPharm Competitive Strengths & Weaknesses
Table 101. SN Biopharm Basic Information, Manufacturing Base and Competitors
Table 102. SN Biopharm Major Business
Table 103. SN Biopharm Peptide Synthesis Product and Services
Table 104. SN Biopharm Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. SN Biopharm Recent Developments/Updates
Table 106. SN Biopharm Competitive Strengths & Weaknesses
Table 107. CBL Basic Information, Manufacturing Base and Competitors
Table 108. CBL Major Business
Table 109. CBL Peptide Synthesis Product and Services
Table 110. CBL Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. CBL Recent Developments/Updates
Table 112. CBL Competitive Strengths & Weaknesses
Table 113. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 114. Piramal Pharma Major Business
Table 115. Piramal Pharma Peptide Synthesis Product and Services
Table 116. Piramal Pharma Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Piramal Pharma Recent Developments/Updates
Table 118. Piramal Pharma Competitive Strengths & Weaknesses
Table 119. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 120. CPC Scientific Major Business
Table 121. CPC Scientific Peptide Synthesis Product and Services
Table 122. CPC Scientific Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CPC Scientific Recent Developments/Updates
Table 124. CPC Scientific Competitive Strengths & Weaknesses
Table 125. Shenzhen Hanyu Basic Information, Manufacturing Base and Competitors
Table 126. Shenzhen Hanyu Major Business
Table 127. Shenzhen Hanyu Peptide Synthesis Product and Services
Table 128. Shenzhen Hanyu Peptide Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Shenzhen Hanyu Recent Developments/Updates
Table 130. Shenzhen Hanyu Competitive Strengths & Weaknesses
Table 131. Global Key Players of Peptide Synthesis Upstream (Raw Materials)
Table 132. Global Peptide Synthesis Typical Customers
LIST OF FIGURES
Figure 1. Peptide Synthesis Picture
Figure 2. World Peptide Synthesis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Peptide Synthesis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Peptide Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Peptide Synthesis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 13. Peptide Synthesis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Peptide Synthesis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Peptide Synthesis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Peptide Synthesis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Peptide Synthesis Markets in 2025
Figure 27. United States VS China: Peptide Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Peptide Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Peptide Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Peptide Synthesis Market Size Market Share by Type in 2025
Figure 31. APIs and Intermediates
Figure 32. Peptide preparations
Figure 33. World Peptide Synthesis Market Size Market Share by Type (2021-2032)
Figure 34. World Peptide Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Peptide Synthesis Market Size Market Share by Application in 2025
Figure 36. Commercial
Figure 37. Academic Research
Figure 38. World Peptide Synthesis Market Size Market Share by Application (2021-2032)
Figure 39. Peptide Synthesis Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Peptide Synthesis Picture
Figure 2. World Peptide Synthesis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Peptide Synthesis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Peptide Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Peptide Synthesis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Peptide Synthesis Revenue (2021-2032) & (USD Million)
Figure 13. Peptide Synthesis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Peptide Synthesis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Peptide Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Peptide Synthesis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Peptide Synthesis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Peptide Synthesis Markets in 2025
Figure 27. United States VS China: Peptide Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Peptide Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Peptide Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Peptide Synthesis Market Size Market Share by Type in 2025
Figure 31. APIs and Intermediates
Figure 32. Peptide preparations
Figure 33. World Peptide Synthesis Market Size Market Share by Type (2021-2032)
Figure 34. World Peptide Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Peptide Synthesis Market Size Market Share by Application in 2025
Figure 36. Commercial
Figure 37. Academic Research
Figure 38. World Peptide Synthesis Market Size Market Share by Application (2021-2032)
Figure 39. Peptide Synthesis Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
